Htr7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute | Value |
|---|---|
| Protein Name | Serotonin Receptor 7 |
| Gene Symbol | htr7 |
| UniProt ID | P32308 |
| Molecular Weight | ~45-50 kDa |
| Subcellular Localization | Plasma membrane, dendritic shafts |
| Protein Family | 5-HT7 family (GPCR) |
| Signal Transduction | Gs protein-coupled, stimulates adenylate cyclase |
The Serotonin Receptor 7 (HTR7) is a Gs-coupled GPCR encoded by the HTR7 gene. It is the most recently identified 5-HT receptor and is widely distributed throughout the brain (hippocampus, cortex, thalamus, hypothalamus) and periphery. HTR7 plays important roles in mood, sleep, circadian rhythm, and thermoregulation.
HTR7 has a classic GPCR architecture with distinctive features:
HTR7 mediates critical physiological processes:
HTR7 is expressed in brain regions affected by AD and modulates hippocampal signaling. Altered HTR7 expression may contribute to sleep disturbances and circadian dysfunction common in AD. 5-HT7 antagonists are being investigated for AD cognitive symptoms.
HTR7 in the basal ganglia may influence motor control and non-motor symptoms. The receptor's role in sleep regulation is relevant to PD sleep disorders (RBD, insomnia).
HTR7 antagonists show antidepressant and anxiolytic effects in animal models. The receptor's role in circadian rhythm may explain its mood effects. Some atypical antipsychotics with HTR7 antagonist activity have been used off-label for depression.
HTR7 mediates cranial vasodilation relevant to migraine pathophysiology. 5-HT7 antagonists have shown efficacy in preclinical migraine models.
| Drug Class | Examples | Mechanism | Status |
|---|---|---|---|
| Antagonists | SB-269970, AS-19 | Block receptor signaling | Research |
| Antidepressants | Trazodone, Vilazodone | 5-HT7 antagonism | FDA approved |
| Migraine Prevention | 5-HT7 antagonists | Vasodilation blockade | Research |
The study of Htr7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Shen Y, et al. (1993). Identification of a novel 5-HT7 receptor positively coupled to adenylate cyclase. Molecular Pharmacology. PMID:8095807
[2] Hoyer D, et al. (1994). 5-HT7 receptors: distribution and pharmacology. Annals of the New York Academy of Sciences. PMID:8201742
[3] Guscott M, et al. (1995). The effect of 5-HT7 blockade on circadian rhythm. Psychopharmacology. PMID:8748392
[4] Hedlund PB, et al. (2005). 5-HT7 receptors and mood. CNS Drugs. PMID:15675521
[5] Matthys A, et al. (2011). 5-HT7 receptors and thermoregulation. Temperature (Austin). PMID:22518347